Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Spontaneous triggering of ovulation versus HCG administration in patients undergoing IUI: a prospective randomized study.

Kyrou D, Kolibianakis EM, Fatemi HM, Grimbizis GF, Theodoridis TD, Camus M, Tournaye H, Tarlatzis BC, Devroey P.

Reprod Biomed Online. 2012 Sep;25(3):278-83. doi: 10.1016/j.rbmo.2012.05.005. Epub 2012 May 23.

PMID:
22796236
2.

An algorithm combining ultrasound monitoring and urinary luteinizing hormone testing: a novel approach for intrauterine insemination timing.

Antaki R, Dean NL, Lapensée L, Racicot MH, Ménard S, Kadoch IJ.

J Obstet Gynaecol Can. 2011 Dec;33(12):1248-52.

PMID:
22166279
3.

Human chorionic gonadotropin administration vs. luteinizing monitoring for intrauterine insemination timing, after administration of clomiphene citrate: a meta-analysis.

Kosmas IP, Tatsioni A, Fatemi HM, Kolibianakis EM, Tournaye H, Devroey P.

Fertil Steril. 2007 Mar;87(3):607-12. Epub 2006 Dec 14.

PMID:
17173907
4.

Early versus late hCG administration to trigger ovulation in mild stimulated IUI cycles: a randomized clinical trial.

da Silva AL, Arbo E, Fanchin R.

Eur J Obstet Gynecol Reprod Biol. 2012 Oct;164(2):156-60. doi: 10.1016/j.ejogrb.2012.05.034. Epub 2012 Jun 27.

PMID:
22743137
5.

Single versus Double Intrauterine Insemination in Controlled Ovarian Hyperstimulation Cycles: A Randomized Trial.

Zahiri Sorouri Z, Rashid Shomali R, Pourmarzi D.

Arch Iran Med. 2016 Jul;19(7):465-9. doi: 0161907/AIM.004.

6.

Do younger women with elevated basal follicular stimulating hormone levels undergoing gonadotropin-stimulated intrauterine insemination cycles represent compromised reproductive outcomes?

Devranoğlu B, Özdamar Ö, Köle E, Eken MK, Bozdağ H, Doğer E.

Eur J Obstet Gynecol Reprod Biol. 2016 Apr;199:141-5. doi: 10.1016/j.ejogrb.2016.01.030. Epub 2016 Feb 8.

PMID:
26930042
7.

Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial.

Lambalk CB, Leader A, Olivennes F, Fluker MR, Andersen AN, Ingerslev J, Khalaf Y, Avril C, Belaisch-Allart J, Roulier R, Mannaerts B.

Hum Reprod. 2006 Mar;21(3):632-9. Epub 2005 Dec 16.

PMID:
16361296
9.

Does intrauterine insemination timing matter for achieving pregnancy during ovulation induction using gonadotropins? A retrospective cohort study.

Yumusak OH, Kahyaoglu S, Pekcan MK, Isci E, Cinar M, Tasci Y.

J Chin Med Assoc. 2017 Jun;80(6):366-370. doi: 10.1016/j.jcma.2016.06.005. Epub 2016 Sep 27.

10.

Luteal phase support in intrauterine insemination cycles: a prospective randomized study of 300 mg versus 600 mg intravaginal progesterone tablet.

Biberoglu EH, Tanrıkulu F, Erdem M, Erdem A, Biberoglu KO.

Gynecol Endocrinol. 2016;32(1):55-7. doi: 10.3109/09513590.2015.1077382. Epub 2015 Aug 18.

PMID:
26291817
11.

Laparoscopic oviductal artificial insemination improves pregnancy success in exogenous gonadotropin-treated domestic cats as a model for endangered felids.

Conforti VA, Bateman HL, Schook MW, Newsom J, Lyons LA, Grahn RA, Deddens JA, Swanson WF.

Biol Reprod. 2013 Jul 5;89(1):4. doi: 10.1095/biolreprod.112.105353. Print 2013 Jul.

PMID:
23699391
12.

Relationship of follicle number, serum estradiol level, and other factors to clinical pregnancy rate in gonadotropin-induced intrauterine insemination cycles.

Ozçakir HT, Göker EN, Terek MC, Adakan S, Ulukus M, Levi R, Tavmergen E.

Arch Gynecol Obstet. 2002 Jan;266(1):18-20.

PMID:
11998958
13.

The impact of premature progesterone rise on the outcome of intrauterine insemination cycles with controlled ovarian hyperstimulation in unexplained infertility.

Mutlu MF, Erdem M, Erdem A, Mutlu I, Guler I, Demirdağ E.

Eur J Obstet Gynecol Reprod Biol. 2016 Aug;203:44-8. doi: 10.1016/j.ejogrb.2016.05.013. Epub 2016 May 20.

PMID:
27236604
14.

Intra-uterine insemination: pregnancy rate in relation to number, size of pre-ovulatory follicles and day of insemination.

Karuppaswamy J, Smedley M, Carter L.

J Indian Med Assoc. 2009 Mar;107(3):141-3, 147.

PMID:
19810378
15.

Time interval from human chorionic gonadotrophin (HCG) injection to follicular rupture.

Andersen AG, Als-Nielsen B, Hornnes PJ, Franch Andersen L.

Hum Reprod. 1995 Dec;10(12):3202-5.

PMID:
8822444
16.

GnRH antagonist ganirelix prevents premature luteinization in IUI cycles: rationale for its use.

Martinez-Salazar J, Cerrillo M, Quea G, Pacheco A, Garcia-Velasco JA.

Reprod Biomed Online. 2009 Aug;19(2):156-61.

PMID:
19712548
18.

Effects of piroxicam administration on pregnancy outcome in intrauterine insemination (IUI) cycles: a randomized clinical trial.

Zarei A, Mahboubi M, Parsanezhad ME, Alborzi S, Younesi M, Madadi G.

Clin Exp Obstet Gynecol. 2016;43(2):225-9.

PMID:
27132415
19.

Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysis.

Kosmas IP, Tatsioni A, Kolibianakis EM, Verpoest W, Tournaye H, Van der Elst J, Devroey P.

Fertil Steril. 2008 Aug;90(2):367-72. Epub 2007 Oct 23.

PMID:
17936285
20.

Effect of luteal phase support after ovulation induction and intrauterine insemination.

Oktem M, Altinkaya SO, Yilmaz SA, Bozkurt N, Erdem M, Erdem A, Gumuslu S.

Gynecol Endocrinol. 2014;30(12):909-12. doi: 10.3109/09513590.2014.947567. Epub 2014 Aug 7.

PMID:
25102275

Supplemental Content

Support Center